RFK Jr.'s Panel Shifts Newborn Hepatitis B Vaccine Policy

A seismic shift in vaccine policy just dropped, and it’s got the public health world buzzing with debate.

On Friday, December 5, 2025, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted 8-3 to scrap the long-standing universal recommendation for hepatitis B shots at birth, limiting it to infants of mothers who test positive or have unknown status, while sparking fierce criticism from traditional health experts, as POLITICO reports.

Since 1991, ACIP has pushed for all newborns to get this vaccine, a move that slashed hepatitis B cases among kids under 15 by a whopping 98% between 1990 and 2006. By 2005, the CDC doubled down, urging the first dose right at birth for everyone.

Policy Change Sparks Heated Controversy

Last week, the landscape looked drastically different. HHS Secretary Robert F. Kennedy Jr. overhauled ACIP, replacing its members with a new crew.

This revamped panel didn’t just tweak policy. They threw out the old playbook. Gone are the rigorous evaluations of yesteryear, replaced by testimonies from anti-vaccine activists like Cynthia Nevison and Mark Blaxill, neither of whom holds a medical degree.

The meeting itself was a mess, marked by procedural chaos and last-minute changes that left even ACIP members scratching their heads about what they were voting on. No career CDC experts presented data on the hepatitis B shot, though some were allowed to answer questions on the fly.

Critics Warn of Rising Health Risks

Under the new guidance, if a mother tests negative for hepatitis B, vaccination timing becomes a discussion with providers, potentially delayed until two months of age. Critics argue this ignores risks like false negatives or late-pregnancy infections, not to mention exposure through infected family or caregivers.

Skeptics of the old policy, however, claim newborns don’t need the shot if mom’s clear, pointing to transmission risks tied mostly to drug use or sexual contact. But public health veterans counter that the U.S. isn’t like European nations with low-risk profiles and tighter health tracking systems.

“Ending the recommendation for newborns makes it more likely the number of cases will begin to increase again,” wrote Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy (R-La.) on X.

Anti-Vaccine Voices Dominate Discussion

Speakers like Blaxill and Nevison leaned hard on unvetted claims, citing payouts from the Vaccine Injury Compensation Fund as proof of harm, though settlements don’t establish causality.

“There is evidence of benefit … and there is no evidence of harm,” said Cody Meissner, a Dartmouth pediatrics professor and ACIP member. Bravo, professor—sometimes the simplest truth cuts through the noise like a hot knife through butter.

The panel also voted 6-4 to float the idea of antibody testing before additional doses, despite zero proof that fewer than three shots offer lifelong protection. This adds another layer of hassle for parents, requiring them to drag kids back for blood draws in an already strained health system.

Future Implications Hang in the Balance

Now, this policy shift isn’t final—it needs CDC endorsement to stick, and it won’t touch insurance coverage for the shot. Most states still mandate hepatitis B vaccines for daycare or school, though exemptions for medical, religious, or personal reasons are widely available.

With anti-vaccine lawyer Aaron Siri slated to speak on the childhood vaccine schedule, it’s clear this committee is steering hard into uncharted, and frankly unsettling, territory.

At the end of the day, hepatitis B isn’t just a minor bug—it can lead to brutal liver disease or cancer if passed from mother to child at birth. While diverse opinions can sharpen debate, swapping science for speculation risks undoing decades of progress, and that’s a gamble no parent should have to take.